蘑菇视频APP

, President and CEO of , describes the company鈥檚 systematic approach to using mRNA therapeutics as epigenetic medicines, with the ability to control abnormal gene expression in a range of diseases, as well as why so many 鈥淥megans鈥� have stayed with the company as it has grown. More from Flagship @ JPM2023 here.